Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wegmann

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Developments in Biological Standardization|January 1, 1986
Comparative study and evaluation of further attenuated, live measles vaccines alone and in combination with mumps and rubella vaccinesA Wegmann, R Glück, M Just, et al.
Schweizerische Medizinische Wochenschrift|February 1, 1986
[Tolerability and pharmacokinetics of an intravenous immunoglobulin preparation in immunologically normal subjects and tolerability in patients with hypogammaglobulinemia resulting from chronic lymphatic leukemia]H J Huser, D Schwander, A Wegmann, et al.
Chemistry and Physics of Lipids|October 1, 1986
Mass spectral behavior and HPLC of some unusual molecular phospholipid speciesA Dasgupta, E Ayanoglu, A Wegmann-Szente, et al.
Annals of Allergy|May 1, 1993
Successful oral acyclovir desensitizationR E Henry, J A Wegmann, J E Hartle, et al.
Deutsche Medizinische Wochenschrift (1946)|March 19, 1993
[Spontaneous rupture of the left hepatic duct]M F Müller, G P Krestin, W Weder, et al.
Schweizerische Medizinische Wochenschrift|November 12, 1994
[Immunogenicity and stability of an aluminum-free liposomal hepatitis A vaccine (Epaxal Berna)]A Wegmann, M Zellmeyer, R Glück, et al.
Lancet (London, England)|November 24, 1984
Confirmation of need for rabies immunoglobulin as well as post-exposure vaccineR Glück, A Wegmann, R Germanier, et al.
Journal of Biological Standardization|January 1, 1980
A highly purified and concentrated duck embroy rabies vaccine: a preliminary reportK R Schell, M Fürst, H U Haberstich, et al.
The Journal of Clinical Investigation|July 1, 1987
Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humansS J Cryz, E Fürer, A S Cross, et al.
The Journal of Infectious Diseases|May 11, 1991
Safety and immunogenicity of Escherichia coli O18 O-specific polysaccharide (O-PS)-toxin A and O-PS-cholera toxin conjugate vaccines in humansS J Cryz, A S Cross, J C Sadoff, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Developments in Biological Standardization|January 1, 1986
Comparative study and evaluation of further attenuated, live measles vaccines alone and in combination with mumps and rubella vaccinesA Wegmann, R Glück, M Just, et al.
Schweizerische Medizinische Wochenschrift|February 1, 1986
[Tolerability and pharmacokinetics of an intravenous immunoglobulin preparation in immunologically normal subjects and tolerability in patients with hypogammaglobulinemia resulting from chronic lymphatic leukemia]H J Huser, D Schwander, A Wegmann, et al.
Chemistry and Physics of Lipids|October 1, 1986
Mass spectral behavior and HPLC of some unusual molecular phospholipid speciesA Dasgupta, E Ayanoglu, A Wegmann-Szente, et al.
Annals of Allergy|May 1, 1993
Successful oral acyclovir desensitizationR E Henry, J A Wegmann, J E Hartle, et al.
Deutsche Medizinische Wochenschrift (1946)|March 19, 1993
[Spontaneous rupture of the left hepatic duct]M F Müller, G P Krestin, W Weder, et al.
Schweizerische Medizinische Wochenschrift|November 12, 1994
[Immunogenicity and stability of an aluminum-free liposomal hepatitis A vaccine (Epaxal Berna)]A Wegmann, M Zellmeyer, R Glück, et al.
Lancet (London, England)|November 24, 1984
Confirmation of need for rabies immunoglobulin as well as post-exposure vaccineR Glück, A Wegmann, R Germanier, et al.
Journal of Biological Standardization|January 1, 1980
A highly purified and concentrated duck embroy rabies vaccine: a preliminary reportK R Schell, M Fürst, H U Haberstich, et al.
The Journal of Clinical Investigation|July 1, 1987
Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humansS J Cryz, E Fürer, A S Cross, et al.
The Journal of Infectious Diseases|May 11, 1991
Safety and immunogenicity of Escherichia coli O18 O-specific polysaccharide (O-PS)-toxin A and O-PS-cholera toxin conjugate vaccines in humansS J Cryz, A S Cross, J C Sadoff, et al.
Pageof 7